GDF9 Antikörper (AA 320-454)
-
- Target Alle GDF9 Antikörper anzeigen
- GDF9 (Growth Differentiation Factor 9 (GDF9))
-
Bindungsspezifität
- AA 320-454
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GDF9 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Growth/differentiation factor 9 protein (320-454AA)
- Isotyp
- IgG
- Top Product
- Discover our top product GDF9 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:200-1:500,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- GDF9 (Growth Differentiation Factor 9 (GDF9))
- Andere Bezeichnung
- GDF9 (GDF9 Produkte)
- Synonyme
- GDF-9 antikoerper, zgc:123030 antikoerper, Gdf-9 antikoerper, growth differentiation factor 9 antikoerper, GDF9 antikoerper, gdf9 antikoerper, Gdf9 antikoerper
- Hintergrund
-
Background: Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells.
Aliases: GDF9Growth/differentiation factor 9 antibody, GDF-9 antibody
- UniProt
- O60383
-